Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

V-9302 (hydrochloride)

V-9302 hydrochloride is a competitive antagonist of transmembrane glutamine flux. V-9302 hydrochloride selectively and potently targets the amino acid transporter ASCT2 (SLC1A5) not ASCT1. V-9302 hydrochloride inhibits ASCT2-mediated glutamine uptake (IC50=9.6 µM) in HEK-293 cells[1].

Product Specifications

CAS Number

2416138-42-4

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

ASCT

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/v-9302-hydrochloride.html

Purity

99.10

Solubility

DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 50 mg/mL (ultrasonic)

Smiles

O=C(O)[C@@H](N)CCN(CC1=CC=CC=C1OCC2=CC=CC(C)=C2)CC3=CC=CC=C3OCC4=CC=CC(C)=C4.[H]Cl

Molecular Formula

C34H39ClN2O4

Molecular Weight

575.14

Precautions

H302, H315, H319, H335

References & Citations

[1]Schulte ML, et al. Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacyin preclinical models. Nat Med. 2018 Feb;24 (2) :194-202.|[2]Jin H, et al. A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer. Elife. 2020;9:e56749. Published 2020 Oct 5.|[3]Edwards DN, et al. Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer. J Clin Invest. 2021;131 (4) :e140100.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

ASCT2

Citation 01

Biochem Pharmacol. 2025 Feb 7:116796.|Biochem Pharmacol. 2025 Jun 7:117047.|J Nanobiotechnology. 2022 May 6;20 (1) :216.|Research Square Print. 2023 Jan 31.|Adv Sci (Weinh) . 2024 Dec 16:e2411479.|Adv Sci (Weinh) . 2025 Aug 10:e07057.|Autophagy. 2025 Jul 23:1-16.|Biomaterials. 2025 Sep 17:326:123726.|bioRxiv. 2024 July 05.|bioRxiv. 2025 Jul 31:2025.07.28.667320.|Cell Death Dis. 2024 Feb 5;15 (2) :111.|Cell Metab. 2022 Dec 6;34 (12) :1999-2017.e10.|Cell. 2024 Oct 31;187 (22) :6251-6271.e20.|FASEB J. 2025 Jul 15;39 (13) :e70774.|Front Pharmacol. 2021 May 14;12:671328.|J Biol Chem. 2022 Apr;298 (4) :101753.|J Control Release. 2023 May:357:460-471.|J Gastroenterol. 2025 Oct 8.|J Virol. 2025 Nov 25;99 (11) :e0098525.|Magn Reson Imaging. 2022 Nov:93:189-194.|Nano Today. 2025 Apr.|Nat Immunol. 2024 Oct;25 (10) :1845-1857.|Npj Imaging. 2025 Aug 1;3 (1) :34.|Pharmaceutics. 2024 Jun 29;16 (7) :877.|Proc Natl Acad Sci U S A. 2024 Mar 26;121 (13) :e2319429121.|University of Maryland. 2024.|University of Regensburg. 2024 Jul 18.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Gm12794 3'UTR Lenti-reporter-Luc Vector
21765084 1.0 µg

Gm12794 3'UTR Lenti-reporter-Luc Vector

Sign In for Pricing
View Details
LETM1 and EF-hand Domain Containing Protein 1, Mitochondrial (LETM1, Leucine Zipper-EF-hand-containing Transmembrane Protein 1) (Biotin)
129063-Biotin 100 µL

LETM1 and EF-hand Domain Containing Protein 1, Mitochondrial (LETM1, Leucine Zipper-EF-hand-containing Transmembrane Protein 1) (Biotin)

Sign In for Pricing
View Details
EFNA2 Antibody - middle region : Biotin (ARP61345_P050-Biotin)
ARP61345_P050-Biotin 100 µL

EFNA2 Antibody - middle region : Biotin (ARP61345_P050-Biotin)

Sign In for Pricing
View Details
Ku-0063794
ENZ-CHM135-0010 10 mg

Ku-0063794

Sign In for Pricing
View Details
BeyoECL Moon
P0018FS 100 mL

BeyoECL Moon

Sign In for Pricing
View Details
HCG Antigen
E62C004 100 µg

HCG Antigen

Sign In for Pricing
View Details